Contribution of vaccines to our understanding of pneumococcal disease

• Published in: Philosophical transactions of the Royal Society of London. Series B. Biological sciences 2011-10, Vol.366 (1579), p.2790-2798
• Main Author: Klugman, Keith P.
• Format: Article
• Language: English
• Subjects: Adult; Adults; Carrier State - microbiology; Child; Children; Conjugate vaccines; Drug Resistance, Bacterial; Epidemiology; Global Health; Hospitalization; Hospitalization - statistics & numerical data; Humans; Mycobacterium; Pneumococcal Infections - diagnosis; Pneumococcal Infections - immunology; Pneumococcal Infections - microbiology; Pneumococcal Infections - prevention & control; Pneumococcal pneumonia; Pneumococcal Vaccines - immunology; Pneumococcus; Pneumonia; Pneumonia, Pneumococcal - diagnosis; Pneumonia, Pneumococcal - immunology; Pneumonia, Pneumococcal - prevention & control; Pneumonia, Pneumococcal - virology; Pulmonary tuberculosis; Streptococcus pneumoniae; Vaccination; Vaccine; Vaccines, Conjugate - immunology; Viral pneumonia
• ISSN: 0962-8436; 1471-2970
• DOI: 10.1098/rstb.2011.0032

Pneumonia is the leading cause of mortality in children in developing countries and is also the leading infectious cause of death in adults. The most important cause of pneumonia is the Gram-positive bacterial pathogen, Streptococcus pneumoniae, also known as the pneumococcus. It has thus become the leading vaccine-preventable cause of death and is a successful and diverse human pathogen. The development of conjugate pneumococcal vaccines has made possible the prevention of pneumococcal disease in infants, but has also elucidated aspects of pneumococcal biology in a number of ways. Use of the vaccine as a probe has increased our understanding of the burden of pneumococcal disease in children globally. Vaccination has also elucidated the clinical spectrum of vaccine-preventable pneumococcal infections; the identification of a biological niche for multiple pneumococcal serotypes in carriage and the differential invasiveness of pneumococcal serotypes; the impact of pneumococcal transmission among children on disease burden in adults; the role of carriage as a precursor to pneumonia; the plasticity of a naturally transformable pathogen to respond to selective pressure through capsular switching and the accumulation of antibiotic-resistance determinants; and the role of pneumococcal infections in hospitalization and mortality associated with respiratory viral infections, including both seasonal and pandemic influenza. Finally, there has been a recent demonstration that pneumococcal pneumonia in children may be an important cause of hospitalization for those with underlying tuberculosis.